2023 - AvKare - Launch 5.10.23 - Bexarotene_Sucralfate
2023 - AvKare - Launch 06.23 - Pasocanazole_Teriflunomide
2023-05-02 Vermont New Drug 3-day Notification
2023-06-29 Vermont New Drug 3-day Notification
Altuviiio VT New Drug Submission 2022 30 day follow-up notification 4_24_23_Final
Alvimopan Caps 12mg 30s - Vermont State Notification (June 2023)
Approved - VT 30 day letter - LIQREV - CMP
Avadel CNS Pharmaceuticals - LUMRYZ announcement 2023-05-01 Vermont
Avadel CNS Pharmaceuticals - LUMRYZ new drug report 2023-05-22 Vermont
BioMarin - Vermont - 3-day Notice Roctavian final 06.29.23.docx
BOND - VT - 2023.06.12 - Bond Rider Address Change
Braeburn New Drug Notice
Braeburn_new drug report_2023-06-24
Celltrion USA Vermont New Drug 30 day Report_Vegzelma_04_26_2023_Signed
Celltrion USA Vermont New Drug Notice_Vegzelma_signed_4_12_2023
Copy of Pharming - OR HB 4005 New Drug Report - GP 5-3
Drug Price Transparency - 3 Day Notice - VT Treprostinil
Drug Price Transparency - 30 Day Notice - VT Cycloserine
Drug Price Transparency - 30 Day Notice - VT Treprostinil
Endo_Vermont 30-Day Notice Template Topiramate_Final
Lenalidomide VT New Drug Report
MAC-VIT-US-0263-1 Oral Solution Transition 1.0 to 2.0 Email_rev7[31] to ABSG
mitoMYcin 20mg VT New Drug Report
MitoMycin 40mg VT New Drug Report
New Drug Gefitinib
New Drug Notice - Elfabrio
New prescription drug report - 4.12.2023
Nitsinone Report
NNI VT 18 V.S.A. 4637(b) 3-Day Notice Sogroya 12June2023
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(b) - ZAVZPRET
Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(c) - NURTEC ODT
OMISIRGE PI
Paclitaxel 30-day Report - Vermont (003)
Par_Vermont 30-Day Notice Everolimus_Final_signed
Pfizer - VT Biohaven Disclosure Letter
Posaconazole Inj 18mg 1v - Vermont State Notification (revised June 2023)
QALSODY - VT 3-Day New Drug Notice
QALSODY - VT 30-Day New Drug Report
Reata Pharmaceuticals Vermont New Drug Notification 3 Day Notice
Shorla Oncology
Sincalide VT 3-Day
State of VT Mitomycin for Injection USP 40mg New Drug Report
Tafinlar and Mekinist Drug Report
Tolmar New Drug 4-4-2023
Topiramate ER Caps 25mg +100mg - Vermont State Notification (May 2023)
Topiramate ER Caps 50mg - New Hampshire State Notification (May 2023)
Topiramate ER Caps 50mg - Vermont State Notification (May 2023)
Vermont New Drug Price Report 5.30.2023 - Lenalidomide PDF
Vermont New Drug Price Report 6.20.2023 - Deferasirox Oral Granules PDF
Vermont NITISINONE 20mg Letter
Vermont Report_Augmentin
Vermont Report_Deferasirox
Vermont Report_Lanalidomide_2
Vermont SDPT Initial Drug Notification - Shorla
Vermont WAC Reporting - Arsenic Trioxide Inj Novaplus 4.25.2023
Vermont_New_Drug_Notice_Final
VT 30 Days Notification - Gamida Cell
VT Act 193 New Drug Notice Zynyz 4.9.23 JW
VT Act 193 New Drug Notice
VT Act 193 New Drug Report Abiraterone Acetate Launch_5.30.23
VT Act 193 New Drug Report Busulfan Launch_5.30.23
VT Act 193 New Drug Report Orenitram Blister Pack and Titration Kits 2.23.23 JW
VT Act 193 New Drug Report Zynyz Final
VT Act 193 New Drug Report_Daybue_4.20.23
VT Lenalidomide 30 Day 2.5-20mg 04-05-23
VT Letter to Office of Attorney General_New Drug Report Email - (Nelarabine)
VT Letter to Office of Attorney General_New Drug Report Email - Abiraterone
VT New Drug Notice - Pharming (Joenja Launch)
VT New Drug Notice 3 Day- Columvi
VT New Drug Notification Pursuant to 18 VSA Sec. 4637(c)
VT New Drug Notification
VT New Drug Pricing Report - Austedo XR
VT New Drug Pricing Report - Lenalidomide Caps
VT New Drug Pricing Report - TOPIRAMATE ER
VT New Drug Pricing Report - TOPIRAMATE ER 25MG 50MG 100MG
VT New Drug Pricing Report -Austedo XR
VT New Drug Pricing Report -UZEDY
VT New Drug Reporting - Elfabrio
VT New Drug Reportings Lenalidomide & Bendamustine 2023.05.25
VT New High-Cost Prescription Drugs_Tafinlar and Mekinist
VT Notice of New Drug Introduction -GEFITINIB TABLET
VT Notice of New Drug Introduction -TOPIRAMATE ER 25MG 50MG 100MG
VT PTR Submission Bendamustine
VT PTR Submission Lenalidomide
VT Report_Gefitinib
VT_11_NewDrugReport 20230426
VT_11_NewDrugReport
VT_11_NewDrugReport_20230420_EstDueDate_20230423_ALVOGEN_archive
VT_NewDrugNotification_Epkinly
VT_NewDrugReport_Epkinly
VT-Notice-of-Introduction-of-New-High-Cost-Prescription-Drugs-Chlorpromazine
VT-Report-of-Introduction-of-New-High-Cost-Prescription-Drugs-Chlorpromazine Oral Solution
Charity R. Clark
Office of the Vermont Attorney General